Cas:1257-19-8 Hexametazidine manufacturer & supplier

We serve Chemical Name:Hexametazidine CAS:1257-19-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Hexametazidine

Chemical Name:Hexametazidine
CAS.NO:1257-19-8
Synonyms:Hexametazidine;Trimetazidine Impurity B;Trimetazidine Impurity 2
Molecular Formula:C24H34N2O6
Molecular Weight:446.53700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.86000
Exact Mass:446.24200
LogP:2.93180

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Hexametazidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Trimetazidine Impurity 2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trimetazidine Impurity 2 Use and application,Trimetazidine Impurity B technical grade,usp/ep/jp grade.


Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. Hexametazidine manufacturer On Friday, the US Association of Flight Attendants — which represents 50,000 flight attendants across 20 airlines — called on the government to work with airlines to discontinue all travel to China until the spread of coronavirus is contained. Hexametazidine supplier But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. Hexametazidine vendor But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. Hexametazidine factory This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.